166PCorrelation of various clinical, imaging and laboratory parameters with outcome in patients with metastatic non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs): Results from a prospective, observational, single institution study

166PCorrelation of various clinical, imaging and laboratory parameters with outcome in patients with metastatic non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs): Results from a prospective, observational, single institution study

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of oncology 2019-04, Vol.30 (Supplement_2)
Hauptverfasser: Rounis, K, Papadaki, C, Makrakis, D, Monastirioti, A, Vamvakas, L, Kalbakis, K, Mavroudis, D, Aggelaki, S
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Supplement_2
container_start_page
container_title Annals of oncology
container_volume 30
creator Rounis, K
Papadaki, C
Makrakis, D
Monastirioti, A
Vamvakas, L
Kalbakis, K
Mavroudis, D
Aggelaki, S
description
doi_str_mv 10.1093/annonc/mdz063.064
format Article
fullrecord <record><control><sourceid>oup</sourceid><recordid>TN_cdi_oup_primary_10_1093_annonc_mdz063_064</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/annonc/mdz063.064</oup_id><sourcerecordid>10.1093/annonc/mdz063.064</sourcerecordid><originalsourceid>FETCH-oup_primary_10_1093_annonc_mdz063_0643</originalsourceid><addsrcrecordid>eNqVkMlOAkEQhlujCbg8gLc6QsJADwOj43WikcQYo94nRU8Brb1MesHg09sIL-ClKqn1_z_GbnI-znlVTNAYa8REtz-8LMa8nJ2yfj4vq-yOz_Iz1ufVtMhu58Wsxy68_-Scl9W06p_08rJ8ra1zpDBIa8CuYItO2uhBKGmkQDUCqXEtzRrQtKBwaR0G63bQoUNNgZyHbxk2YGMQVhNIk1pBkgnHRhpCH1JJQJKZeY1KgaAUVExnBRpBDgYv7_VzPYTgCAO1h1WpdTQEYkPiq7PShHR9I5cyCfAwWNQLP7yHN_JRpWcrZzUgdM76jkSQWxqBXXpy2z9zeys--VB7iT7IEP8s-xDb3RU7X6HydH3Ml2z0-PBRP2U2dk3nEgG3a3Le7Gk3B9rNgXaTaBf_HP8FHEyQ6w</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>166PCorrelation of various clinical, imaging and laboratory parameters with outcome in patients with metastatic non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs): Results from a prospective, observational, single institution study</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Rounis, K ; Papadaki, C ; Makrakis, D ; Monastirioti, A ; Vamvakas, L ; Kalbakis, K ; Mavroudis, D ; Aggelaki, S</creator><creatorcontrib>Rounis, K ; Papadaki, C ; Makrakis, D ; Monastirioti, A ; Vamvakas, L ; Kalbakis, K ; Mavroudis, D ; Aggelaki, S</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdz063.064</identifier><language>eng</language><publisher>Oxford University Press</publisher><ispartof>Annals of oncology, 2019-04, Vol.30 (Supplement_2)</ispartof><rights>The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Rounis, K</creatorcontrib><creatorcontrib>Papadaki, C</creatorcontrib><creatorcontrib>Makrakis, D</creatorcontrib><creatorcontrib>Monastirioti, A</creatorcontrib><creatorcontrib>Vamvakas, L</creatorcontrib><creatorcontrib>Kalbakis, K</creatorcontrib><creatorcontrib>Mavroudis, D</creatorcontrib><creatorcontrib>Aggelaki, S</creatorcontrib><title>166PCorrelation of various clinical, imaging and laboratory parameters with outcome in patients with metastatic non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs): Results from a prospective, observational, single institution study</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqVkMlOAkEQhlujCbg8gLc6QsJADwOj43WikcQYo94nRU8Brb1MesHg09sIL-ClKqn1_z_GbnI-znlVTNAYa8REtz-8LMa8nJ2yfj4vq-yOz_Iz1ufVtMhu58Wsxy68_-Scl9W06p_08rJ8ra1zpDBIa8CuYItO2uhBKGmkQDUCqXEtzRrQtKBwaR0G63bQoUNNgZyHbxk2YGMQVhNIk1pBkgnHRhpCH1JJQJKZeY1KgaAUVExnBRpBDgYv7_VzPYTgCAO1h1WpdTQEYkPiq7PShHR9I5cyCfAwWNQLP7yHN_JRpWcrZzUgdM76jkSQWxqBXXpy2z9zeys--VB7iT7IEP8s-xDb3RU7X6HydH3Ml2z0-PBRP2U2dk3nEgG3a3Le7Gk3B9rNgXaTaBf_HP8FHEyQ6w</recordid><startdate>20190401</startdate><enddate>20190401</enddate><creator>Rounis, K</creator><creator>Papadaki, C</creator><creator>Makrakis, D</creator><creator>Monastirioti, A</creator><creator>Vamvakas, L</creator><creator>Kalbakis, K</creator><creator>Mavroudis, D</creator><creator>Aggelaki, S</creator><general>Oxford University Press</general><scope/></search><sort><creationdate>20190401</creationdate><title>166PCorrelation of various clinical, imaging and laboratory parameters with outcome in patients with metastatic non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs): Results from a prospective, observational, single institution study</title><author>Rounis, K ; Papadaki, C ; Makrakis, D ; Monastirioti, A ; Vamvakas, L ; Kalbakis, K ; Mavroudis, D ; Aggelaki, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-oup_primary_10_1093_annonc_mdz063_0643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rounis, K</creatorcontrib><creatorcontrib>Papadaki, C</creatorcontrib><creatorcontrib>Makrakis, D</creatorcontrib><creatorcontrib>Monastirioti, A</creatorcontrib><creatorcontrib>Vamvakas, L</creatorcontrib><creatorcontrib>Kalbakis, K</creatorcontrib><creatorcontrib>Mavroudis, D</creatorcontrib><creatorcontrib>Aggelaki, S</creatorcontrib><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rounis, K</au><au>Papadaki, C</au><au>Makrakis, D</au><au>Monastirioti, A</au><au>Vamvakas, L</au><au>Kalbakis, K</au><au>Mavroudis, D</au><au>Aggelaki, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>166PCorrelation of various clinical, imaging and laboratory parameters with outcome in patients with metastatic non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs): Results from a prospective, observational, single institution study</atitle><jtitle>Annals of oncology</jtitle><date>2019-04-01</date><risdate>2019</risdate><volume>30</volume><issue>Supplement_2</issue><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Oxford University Press</pub><doi>10.1093/annonc/mdz063.064</doi></addata></record>
fulltext fulltext
identifier ISSN: 0923-7534
ispartof Annals of oncology, 2019-04, Vol.30 (Supplement_2)
issn 0923-7534
1569-8041
language eng
recordid cdi_oup_primary_10_1093_annonc_mdz063_064
source EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title 166PCorrelation of various clinical, imaging and laboratory parameters with outcome in patients with metastatic non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs): Results from a prospective, observational, single institution study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T13%3A25%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=166PCorrelation%20of%20various%20clinical,%20imaging%20and%20laboratory%20parameters%20with%20outcome%20in%20patients%20with%20metastatic%20non-small%20cell%20lung%20cancer%20(NSCLC)%20treated%20with%20immune%20checkpoint%20inhibitors%20(ICIs):%20Results%20from%20a%20prospective,%20observational,%20single%20institution%20study&rft.jtitle=Annals%20of%20oncology&rft.au=Rounis,%20K&rft.date=2019-04-01&rft.volume=30&rft.issue=Supplement_2&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdz063.064&rft_dat=%3Coup%3E10.1093/annonc/mdz063.064%3C/oup%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/annonc/mdz063.064&rfr_iscdi=true